Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples